Cargando…
Paradoxical Role of High Mobility Group Box 1 in Glioma: A Suppressor or a Promoter?
Gliomas represent 60% of primary intracranial brain tumors and 80% of all malignant types, with highest morbidity and mortality worldwide. Although glioma has been extensively studied, the molecular mechanisms underlying its pathology remain poorly understood. Clarification of the molecular mechanis...
Autores principales: | Seidu, Richard A., Wu, Min, Su, Zhaoliang, Xu, Huaxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364998/ https://www.ncbi.nlm.nih.gov/pubmed/28382190 http://dx.doi.org/10.4081/oncol.2017.325 |
Ejemplares similares
-
Pivotal neuroinflammatory and therapeutic role of high mobility group box 1 in ischemic stroke
por: Richard, Seidu A., et al.
Publicado: (2017) -
Elucidating the novel biomarker and therapeutic potentials of High-mobility group box 1 in Subarachnoid hemorrhage: A review
por: Richard, Seidu A.
Publicado: (2019) -
Clinical and prognostic significance of high-mobility group box-1 in human gliomas
por: WANG, XIN-JUN, et al.
Publicado: (2015) -
High-mobility group box 1: role in ARDS
por: Ishizaka, A, et al.
Publicado: (2005) -
The Role of High Mobility Group Box 1 in Innate Immunity
por: Lee, Shin-Ae, et al.
Publicado: (2014)